A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO7443904 in Combination With Glofitamab in Participants With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma

Clinical trial NCT05219513 · TERMINATED

Trial details

NCT number: NCT05219513
Sponsor: Hoffmann-La Roche
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Lymphoma, Non-Hodgkin

Start date: 2022-02-18
Primary completion: 2024-07-17
Enrollment: 53

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.